Remdesivir
Form: Lyophilized powder for IV & Injection
Strength: Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)
Reference Brands: Veklury® (EU & US)
Category: Anti Covid Medicines
Remdesivir (Veklury) is a broad-spectrum antiviral approved in the EU and US for the treatment of hospitalized COVID-19 patients. Manufactured by Gilead Sciences, Remdesivir is available as a 100 mg lyophilized powder and 100 mg/20 mL injection solution. As a key product in critical care, it is in demand across hospitals, distributors, and government tenders. Pharmab2B platforms connect verified Remdesivir suppliers, manufacturers, and wholesalers for compliant sourcing. Ensure regulatory-approved procurement in Europe and the United States through trusted B2B pharmaceutical networks offering competitive pricing, supply reliability, and global shipping.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details